3-iodobenzylguanidine has been researched along with Bladder Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komatsu, K; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Bladder Diseases
| Article | Year |
|---|---|
Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Constipation; Data Interpretation, Statistical; Disability Evaluation; Female; Heart; Humans; Hypotension, Orthostatic; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Diseases | 2006 |